Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from TGA

Ultra Violette Pulls Popular Sunscreen As New Testing Reveals Inconsistent Protection

The sunscreen saga continues....

Pedestrian.tv

Ultra Violette pulls Lean Screen sunscreen from shelves as new tests find ‘inconsistent’ SPF protection

Company had initially challenged a Choice investigation that questioned SPF claims

The Guardian - AU

Two years on from Australia’s bold psychedelic experiment, here are our concerns

A small Australian trial that used psychedelic-assisted therapy to improve the mental health and wellbeing of terminally ill patients is in the news today.

The Conversation

From analysis to the latest developments in health,
read the most diverse news in one place.

Is spinal cord stimulation safe? Does it work? Here’s what you need to know if you have back pain

Spinal cord stimulators are electrical devices that are surgically implanted in the body to treat long-term pain. They have a battery pack and leads that deliver electrical impulses directly to the spinal cord. The devices are thought to work by providing electrical impulses that interfere with how the brain senses…

The Conversation

An expert explains why you shouldn’t abandon sunscreen despite the fearmongering

A pharmacology expert says the threat of cancer from sun exposure is far more serious than any potential negative effects from sunscreens

The Independent UK

How safe are the chemicals in sunscreen? A pharmacology expert explains

Last week, the Therapeutic Goods Administration (TGA) released its safety review of seven active ingredients commonly used in sunscreens.

The Conversation

Confusing for doctors, inequitable for patients: why Australia’s medicinal cannabis system needs urgent reform

In 2024 alone, Australia’s medicines regulator, the Therapeutic Goods Administration (TGA), authorised at least 979,000 prescription applications for medicinal cannabis through its specialised access pathways.

The Conversation

Read news from The Economist, FT, and more,
with one subscription

Can I trust my sunscreen? Choice test results have created uncertainty over SPF claims and lab testing process

With Australia having one of the highest rates of skin cancer in the world, the consumer advocate group’s report left many worried and wondering about the brands they use

The Guardian - AU

The danger of too much vitamin B6 – and three symptoms to look out for

The Australian regulator admits it may have underestimated the extent of the side effects from vitamin B6 supplements

The Independent UK

Does Australia really take too long to approve medicines, as the US says?

Australia’s drug approval system is under fire, with critics in the United States claiming it is too slow to approve life-saving medicines.

The Conversation

What Gen Z Needs To Know About Crackdowns On Medical Cannabis Prescriptions

Australia's health-practitioner watchdog has released guidance for doctors prescribing medicinal cannabis, noting current data has raised "red flags".

Pedestrian.tv

Australia’s Top Sunscreen Brands May Need To Change Their Formulas Following A Review

Sunscreen manufacturers in the country may soon need to reformulate their products to add safeguards regarding two active ingredients.

Pedestrian.tv

Too much vitamin B6 can be toxic. 3 symptoms to watch out for

Side effects from taking too much vitamin B6 – including nerve damage – may be more widespread than we think, Australia’s medicines regulator says.

The Conversation

Australians with ADHD could face drug shortages for rest of year, TGA says

People with neurodevelopmental disorder advised to contact their doctor while experts say alternative medications available

The Guardian - AU

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - AU

Ban on gay and bisexual men donating blood and plasma in Australia to be scrapped

Lifeblood heralds ‘world-leading plasma pathway’ amid change to HIV-era restrictions

Pedestrian.tv

Australia’s Sunscreen Saga Continues As CHOICE Doubles Down On Test Results

CHOICE has doubled down on its recent sunscreen testing, which found only four out of 20 popular sunscreens met their label claim of SPF50.

AAP

Low pharmacy vaping uptake fuels black market fears

Only about 40,000 vapes have been sold via the federal government's pharmacy model, which critics say shows black market sales are still thriving.

The Conversation

The weight loss drug Mounjaro has been approved to treat sleep apnoea. How does it work?

Last week, Australia’s Therapeutic Goods Administration (TGA) approved the weight-loss drug Mounjaro to treat sleep apnoea, a condition in which breathing stops and starts repeatedly during sleep.

Get all your
news in one place.

100's of premium titles.
One news app.

Pedestrian.tv

Australia's peak consumer advocacy group put 20 sunscreens to the test, finding most didn’t actually hit the SPF50 mark.

AAP

Four in five sunscreens fail SPF test: consumer group

The Cancer Council is disputing the findings of tests on popular sunscreens in Australia that show 16 out of 20 don't match the SPF 50+ ratings on their tubes.

The Guardian - AU

Several leading Australian sunscreens don’t provide the protection they say, Choice finds

Consumer group tested 20 popular SPF 50 and 50+ brands and found 16 didn’t meet the claims on the bottles

AAP

Tech giant sued over sleep aid foam inhalation 'risk'

Recalled Philips sleep apnoea devices posed dangers for users inhaling or ingesting small pieces of foam due to degradation, a government lawsuit claims.

The Conversation

The TGA has approved donanemab for Alzheimer’s disease. How does this drug work and who will be able to access it?

This week, Australia’s Therapeutic Goods Administration (TGA) approved a drug called donanemab for people in the early stages of Alzheimer’s disease.

Fortune

'Hated' Ethereum due for a comeback says crypto icon Arthur Hayes

The BitMEX founder thinks a spending spree by the U.S. Treasury will help lift the price of Bitcoin.

The Conversation

More people are trying medicinal cannabis for chronic pain. But does it work?

More Australians than ever are being prescribed medicinal cannabis.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.